Follow Us On

Facebook  X  Linkedin  YouTube
 
 

We look forward to seeing everyone next year in Orlando!

Registration begins October 2026.

Mark your calendars! ASIPP's 29th Annual Meeting will take place April 15-17, 2027.

Thank you to everyone for making this year's Annual Meeting a success!

Physicians Are Not Providers, Says ACP Drawing New Attention to Old Debate

Please don’t call us “providers.” 


In a position paper published in the Annals of Internal Medicine, a group of physicians argue that the term lumps them with businesses such as insurance companies and hospitals and clinicians with less training than MDs. 


“With the ongoing attacks on physicians, science, our very profession, it needs to really be reinforced how offensive, dehumanizing, and deprofessionalizing the term provider is,” said Jason Goldman, MD, president of the American College of Physicians (ACP), in an interview. 


Physicians undergo extensive training and make complex evaluations of patients to determine the best mode of treatment, a notable difference from an entity that ‘provides’ a service, according to the paper from the ACP. 


Click here to read the full article.

The Opportunity:

  • Well-established group seeking an interventional pain physician with pain fellowship training
  • Comprehensive interventional pain management program with physicians, nurse practitioners, and two Ambulatory Surgery Centers
  • Established interventional pain management practice with strong clinical and research focus
  • High-volume practice that is ethical and fully legally compliant
  • Research and publication opportunities available
  • Early and generous partnership opportunities in both the practice and ASC


The Community:

  • Excellent quality of life in a county of more than 60,000 residents, with a regional drawing area exceeding 200,000
  • High standard of living with abundant recreational and social opportunities
  • Strong public school system and a private parochial elementary school
  • Convenient location: approximately 2.5 hours to Nashville and St. Louis; 3 hours to Memphis, Louisville, and Lexington
  • Daily one-hour flights to major international hubs, including Chicago O’Hare and Houston, TX


Please email Cindy Jackson at cindy@thepainmd.com with your current CV to schedule an interview or to learn more about this practice.




GLP-1s Prevent Death as a Result of Substance Use Disorders




Clinical evidence has long suggested that the use of GLP-1 medications is linked to lower substance use. It’s also been speculated among patients taking the medications. Social drinkers, for example, contend that they no longer have the urge to order that glass of wine when they’re out with friends and smokers are finally able to stop.


Now a larger body of research shows what physicians and their patients have long noticed: Taking GLP-1 medications seems to significantly prevent and reduce addiction and substance use disorders. In a study published recently in The BMJ, researchers followed about 600,000 veterans with type 2 diabetes and found that GLP-1s prevented and treated substance use disorders when taken over a 3-year period.


The Most Surprising Aspect of GLP-1s

The most surprising outcome was that GLP-1s seem to reduce bad outcomes in those with a substance use disorder. Specifically, the study showed a 50% reduction in drug-related deaths and 40% reduced risk for drug overdoses. Researchers noted significantly fewer drug-related hospitalizations, drug-related emergency department visits, and suicide attempts.


Click here to read the full article.

Our Sponsor

ASIPP is pleased to announce the launch of the Regenerative and Longevity Medicine Section!


This section reflects the growing importance of regenerative and longevity medicine—fields dedicated to restoring health, enhancing vitality, and extending the healthy years of life. From stem cell therapies and tissue engineering to gene therapy and orthobiologics, these disciplines are transforming the way we approach pain management and age-related decline.


Section membership offers:

  • Access to ASIPP’s physician database and future data registry
  • Opportunities for certification and continuing education
  • Section-exclusive resources and updates


Click here to apply.

No additional cost for ASIPP members!

ASIPP is proud to launch our Resident and Fellow Mentorship Program. This initiative is designed to connect trainees with experienced pain physicians to foster professional growth, provide guidance, and strengthen the future of our specialty.


Each mentor would be paired with one to two trainees, but can take more if interested. Trainees will be responsible for initiating introductions and arranging at least one to two video calls per year. These sessions will provide opportunities for mentees to seek advice on clinical decision-making, career planning, research opportunities, and professional development.


We believe that your experience, expertise, and insight can have a lasting impact on the next generation of pain physicians. By volunteering as a mentor, you will play a critical role in shaping the future of our field and ensuring that ASIPP continues to cultivate excellence in interventional pain medicine.


If you are interested in serving as a mentor, please confirm your participation by filling out the appropriate form below.





5 Million Deaths Tied to Global Inactivity





People worldwide are not getting enough physical activity — despite long-running promotion efforts. About 80% of young adults move less than recommended by the World Health Organization (WHO), an international research team found in a qualitative case study published in Nature Health, one of three studies in a series. Physical inactivity is associated with an increased risk for premature death and is responsible for about 5 million deaths per year worldwide. That is comparable to the number of deaths caused by smoking or excess weight.


Yet many measures, promotion initiatives, and strategies to increase physical activity were recommended by international health organizations between 2004 and 2023. Globally, however, less than half of those recommendations were implemented. Andrea Ramírez Varela, MD, Department of Epidemiology, School of Public Health, University of Texas Health Science Center at Houston, and her colleagues discuss several factors that can hinder implementation: a lack of interdisciplinary approaches, disagreement about the importance of promoting physical activity, and a lack of resources in the form of responsible ministries or institutional structures.


In Germany, statutory health insurers (the country’s public health insurance funds) offer incentive programs and preventive courses, daycare centers and schools run physical activity programs, and workplace health promotion is supported through tax incentives. Municipal and national strategies round out these efforts. Still, Germany ranks only in the lower middle for implementing physical activity prevention measures on the Public Health Index — “Health Protection in European Comparison 2025.”


Click here to read the full article.

Our Sponsor

Misinformation Abounds in Influencers' Promotion of Prescription Drugs

Systematic review turned up inaccurate or misleading advice,
weak regulatory oversight


Key

Takeaways


• The promotion of prescription drugs by social media influencers is growing.


•  This type of promotion carries public health risks, authors of a systematic review said.


•  Recurrent themes in posts about prescription drugs by influencers included misinformation and blurred lines between personal testimony and paid promotion, with weak regulatory oversight.

Don't expect accuracy and transparency in the promotion of prescription drugs by social media influencers, researchers cautioned.


Though evidence was limited in this systematic scoping review, recurrent themes in posts about prescription drugs by influencers included misinformation and blurred lines between personal testimony and paid promotion, with weak regulatory oversight, reported Raffael Heiss, PhD, of the Center for Social and Health Innovation at the MCI Management Center Innsbruck in Austria, and colleagues.


Click here to read the full article.


Apply now for one of the following dates:


April 18, May 23, & June 27, 2026



  • ABIPP Part I

Four (4) hour virtual exam


  • ABIPP Path – Combined CCPM/ CSM Exam

For those with subspecialty in Pain Medicine

Two (2) hour virtual exam


  • ABIPP Competency Exam in IPM

For those without primary board certification

Two (2) hour virtual exam


  • ABIPP Competency Exam in Regenerative Medicine

Two (2) hour virtual exam


  • Controlled Substance Management Competency Exam

Two (2) hour virtual exam


  • Documentation, Coding, Compliance, Practice Management Competency Exam

Two (2) hour virtual exam

Exam Dates

 

We're excited to let you know that the new ASIPP Community, hosted by DocMatter, is now live!


The ASIPP Community on DocMatter will serve as a place for members to collaborate around clinical and research topics to advance the care of their interventional pain patients.


Click here to be a part of the conversation!

Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.


Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer review and quality control as any other scholarly journal.


Interested in becoming a member of the PMCR Editorial Board?

Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.


For more information or to submit your articles, click here.

We are excited to announce that Pain Medicine Case Reports (PMCR) journal (eISSN 2768-5152) has been accepted for inclusion in MEDLINE and PubMed, the prestigious bibliographic database of the U.S. National Library of Medicine. PMCR, a companion publication to the prestigious Pain Physician journal by ASIPP, joins its counterpart in achieving indexing in both MEDLINE and PubMed, marking ASIPP’s dual presence in these renowned databases.


The inclusion of PMCR journal in MEDLINE signifies a higher level of selectivity, as MEDLINE consists of the top 5,200 biomedical journals. This indexing also means that articles from PMCR will be searchable using NLM Medical Subject Headings (MeSH terms) and other metadata.


The selection for MEDLINE follows a rigorous evaluation process by reviewers from the Literature Selection Technical Review Committee (LSTRC). According to their criteria, the scientific quality of a journal’s content is the primary factor considered for indexing.


We extend our congratulations to the Pain Medicine Case Reports Editor-in-Chief, Deputy Editor-in-Chief, Journal Team, and Editorial Board for this achievement, which underscores the significance and excellence of this esteemed journal.

 

CASE REPORTS

Computed Tomography-Guided Short-Term Gasserian Ganglion Stimulation for the Treatment of Idiopathic Trigeminal Neuralgia: A Two-Case Report


Wei Zhao, MD, Zheng Li, MD, Jie Ju, BS, Jie Liu, MD, Xiaoling Peng, MD, Tiantian Chu, MD, Jihao Ren, BS, and Feng Gao, PhD

Peripheral Nerve Stimulator Lead Fracture and Indolent Infection Requiring Surgical Explant: A Case Report


Beau P. Sperry, MD, Michael A. Mooney, MD, and Alexander J. Kim, MD

 
 
 

RETROSPECTIVE STUDIES

Real-World Insights into Dual Calcitonin Gene-Related Peptide (CGRP) Therapies for Chronic Migraine: A Retrospective Review


Ho Hyun Lee, Anita J. Cheung, MPH, Anson Y. Lee, Julia R. Jahansooz, MS, Edward J. Weldon, Kyle M. Ishikawa, MD, Reyn Yoshioka, Man Ian Woo, Lana Liquard, Eonjung Angeline Kim, MD, Enrique Carrazana, MD, and Kore K. Liow, MD

Minimally Invasive Sacroiliac Joint Fusion Using 3D Printed Implants and a Lateral Approach: Safety and Effectiveness Assessments of Fusion Performed by Interventional Physicians in a Prospective Multicenter Single-Arm Clinical Study (The FICS Study)


Douglas P. Beall, MD, Ty Ptacek, MD, Ashley M. Classen, CO, Michael Jung, MD, Matthew Skoblar, MD, John Hatheway, MD, Olivia A. Beall, MA, Matthew C. Shonnard, MD, and Reade DeLeacy, MBBS

Computed Tomography-Guided Celiac Plexus Block and Neurolysis: Technical Outcomes and Complications


Mary Daniels, MD, Edgardo Duran, BS, Vincent Pan, BS, Peter Rentzepis, BS, Thomas An, MD, Ashraf Thabet, MD, and David Hao, MD




ASIPP is in collaboration with Curi Medical Liability Program




Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices. 

 

Curi is a full-service advisory firm that serves physicians and their practices. Their valued advice is grounded in your priorities and elevated in your outcomes. They are driven by a deep understanding of your specific circumstances in medicine, business, and life. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary risk management CME activities, visit our website.



IMPORTANT UPDATE

SPRINT no longer classified as PNT 



SPR is happy to announce an important update regarding Humana Medicare Advantage. As of May 1, Humana is now recognizing SPRINT as a PNS therapy. Previously, SPRINT was categorized as PNT (Percutaneous Nerve Stimulation), which allowed denials on the grounds that the therapy fell outside the NCD.


Additional details are as follows:

Payer: Humana Medicare Advantage (click here to view policy)

Policy Title: Peripheral Nerve Stimulators

Policy changes: SPRINT no longer misclassified as PNT and is now appropriately classified as PNS. Humana is applying the Noridian Medicare LCD criteria to ALL PNS devices – Including SPRINT PNS!

Effective Date: 5/1/2025


Click here to view a PDF of the official policy update.

 

Group Purchasing Organization Offer Better Pricing and Creates Added Value


ASIPP has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for independent physicians. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.



Learn More


For updated information concerning tariffs on products, click here.

 
 

ASIPP, Fedora Healthcare Solutions Partnership


ASIPP offers our members the benefit of a unique revenue cycle management/ billing service.



We have received a tremendous amount of interest in the ASIPP billing and coding program.




Click here to learn more about the negotiated rate for practices and more!

Like and Follow ASIPP® on Facebook, X, LinkedIn,

and YouTube for the most up-to-date news

related to you, your practice, and your patients!